Merrimack Pharmaceuticals (MACK)

Add to Watchlists
Create an Alert
4.52 +0.02  +0.44% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
MACK Price Chart
View All Events

MACK Events

Date Type Description
Feb 27 Misc Merrimack Pharmaceuticals Inc Q4 2013 Earnings Conference Call
Feb 27 Earnings Merrimack Pharmaceuticals Inc Q4 2013 Earnings Results. Estimate: -0.34.
Nov 07 Misc Merrimack Pharmaceuticals Announces Timing of Third Quarter 2013 Investor Conference Call
Nov 07 Earnings Merrimack Pharmaceuticals Announces Timing of Third Quarter 2013 Results. Estimate: -0.34.
Aug 08 Misc Merrimack Pharmaceuticals Announces Timing of Second Quarter 2013 Investor Conference Call
Aug 08 Earnings Second Quarter 2013 Release. Estimate: -0.29.
May 13 Misc Merrimack Pharmaceuticals Announces Timing of First Quarter 2013 Investor Conference Call
May 13 Earnings Merrimack Pharmaceuticals Announces Timing of First Quarter 2013 Earnings Results. Estimate: -0.29.
View All Performance Charts

MACK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Merrimack Pharmaceuticals is down 26.74% over the last year vs S&P 500 Total Return up 20.96%, Actelion up 66.30%, and Jazz Pharmaceuticals up 157.9%.

Get Quote for

PDF Report for MACK

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download MACK Pro Report PDF
Advertisement

Portfolio Strategies Featuring MACK

Did Merrimack Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MACK Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
MACK 4.52 +0.02 +0.44% 465.73M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.